Using an Old Test for New Tricks: Measuring Direct Oral Anti-Xa Drug Levels by Conventional Heparin-Calibrated Anti-Xa Assay

American Journal of Hematology - United States
doi 10.1002/ajh.25434
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Rivaroxaban: An Oral Direct Inhibitor of Factor Xa

American Journal of Health-System Pharmacy
MedicineHealth PolicyPharmacologyPharmacy
2008English

Antithrombotic Drug and Its Clinical Indication. Factor Xa Inhibitor. Oral Xa Inhibitor (DX-9065a).

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1996English

A Retrospective Analysis of Correlation Between APTT and Anti-Xa Levels Using Ex Vivo Plasma Samples From Patients on Intravenous Heparin Therapy

Pathology
Forensic MedicinePathology
2020English

Current Status and Future of Anti-Xa Inhibitors

Clinical Neurology
Neurology
2011English

Interlaboratory Agreement in the Monitoring of Unfractionated Heparin Using the Anti-Factor Xa-Correlated Activated Partial Thromboplastin Time

Journal of Thrombosis and Haemostasis
MedicineHematology
2009English

Fibrin-Targeted Direct Factor Xa Inhibition: Construction and Characterization of a Recombinant Factor Xa Inhibitor Composed of an Anti-Fibrin Single-Chain Antibody and Tick Anticoagulant Peptide

Thrombosis and Haemostasis
Hematology
2004English

Ixolaris: A Factor Xa Heparin-Binding Exosite Inhibitor

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2005English

Effect of Famotidine on the Pharmacokinetics of Apixaban, an Oral Direct Factor Xa Inhibitor

Clinical Pharmacology: Advances and Applications
Pharmacology
2013English

Engineered Factor Xa Variants Retain Procoagulant Activity Independent of Direct Factor Xa Inhibitors

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy